Study to Compare 2 Formulations of LY900014 in Healthy Participants
NCT03616977
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY900014 U-200
DRUG:
LY900014 U-100
Sponsor
Eli Lilly and Company